Victor R. Gordeuk

Sep 14, 2023 | nature.com | Victor R. Gordeuk

Correction to: Scientific Reports https://doi.org/10.1038/s41598-023-40039-2, published online 08 August 2023The original version of this Article contained errors in Figure 3.

Jun 22, 2023 | onlinelibrary.wiley.com | Jin H. Han |Santosh L. Saraf |Victor R. Gordeuk

Abstract Sickle cell disease (SCD) is an immunocompromised condition and patients with SCD may have a reduced immune response to certain vaccinations. The report by Nakahara et al. demonstrated that SCD patients exhibited elevated and more sustained IgG production following COVID-19 vaccination, when compared to healthy controls. This suggests that the immune response to vaccinations may vary among different types of vaccines in individuals with SCD. Commentary on: Nakahara et al.